CONSOLIDATED STATEMENTS OF CHANGES IN SHAREHOLDERS’ EQUITY - USD ($) $ in Thousands	Shares of Common Stock	Common Stock and Additional Paid in Capital	Retained Earnings	Accumulated Other Comprehensive Income (Loss)	Total
Balance, beginning of period at Dec. 31, 2017		$ 61,981	$ 19,711	$ (292)	$ 81,400
Balance (in shares) at Dec. 31, 2017	6,294,930
Increase (Decrease) in Shareholders' Equity
Net income			8,367		8,367
Other comprehensive income (loss):
Net change in unrealized gain on securities available for sale				(174)	(174)
Actuarial loss on defined benefit pension obligation				3	3
Total comprehensive income				(171)	8,196
Stock compensation		533			533
Restricted stock award vesting (in shares)	45,630
FFNM acquisition		34,101			$ 34,101
FFNM acquisition (in shares)	2,146,378				2,146,378
Capital raise, net of offering costs		32,451			$ 32,451
Capital raise, net of offering costs (in shares)	2,225,807
Dividend on common stock			(4,612)		(4,612)
Balance, end of period at Dec. 31, 2018		129,066	23,466	(463)	152,069
Balance (in shares) at Dec. 31, 2018	10,712,745
Increase (Decrease) in Shareholders' Equity
Net income			13,850		13,850
Other comprehensive income (loss):
Net change in unrealized gain on securities available for sale				1,270	1,270
Actuarial loss on defined benefit pension obligation				(192)	(192)
Total comprehensive income				1,078	14,928
Stock compensation		498			498
Restricted stock award vesting (in shares)	35,967
Dividend on common stock			(5,576)		(5,576)
Balance, end of period at Dec. 31, 2019		$ 129,564	$ 31,740	$ 615	$ 161,919
Balance (in shares) at Dec. 31, 2019	10,748,712